Industry Insights

  • Upadacitinib: A Pill for Crohn’s Disease
    Upadacitinib: A Pill for Crohn’s Disease David Orchard-Webb
    March 01, 2024
    Recently, the U.S. Food and Drug Administration (FDA) approved a groundbreaking oral medication called Upadacitinib (upadacitinib) for adults with moderately to severely active Crohn's disease.
  • Advertising Email to: Julia.zhang@imsinoexpo.com

  • Media Cooperation Email to: Jennifer.Yang@imsinoexpo.com
  • Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

    Note: You can unsubscribe from the alerts at any time.

EZBuy
Livestream & Activity
Conference & Forum
PharmaSources Customer Service